Technology Assisted Treatment for Trichotillomania
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2021
CompletedFirst Posted
Study publicly available on registry
November 12, 2021
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
February 23, 2026
February 1, 2026
6 months
November 2, 2021
February 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinician-rated trichotillomania (TTM) symptom severity at endpoint (week 8)
Scores on the NIMH Trichotilomania Severity Scale (NIMH-TSS), a clinician-administered assessment of TTM symptom severity, will be compared across conditions at endpoint (week 8), controlling for baseline severity. The NIMH-TSS is a 5-item clinician rated measure of TTM severity ranging from 0-25, with higher scores indicating more severe symptoms.
Eight weeks
Secondary Outcomes (1)
Self-reported trichotillomania (TTM) severity at endpoint (week 8)
8 weeks
Study Arms (2)
Keen2 bracelet and app
EXPERIMENTAL8-week intervention involving a wrist-worn motion detection device (Keen2 bracelet) and accompanying smartphone app that delivers components of behavior therapy for TTM.
Reminder bracelet and health tips app
PLACEBO COMPARATOR8-week intervention involving a wrist-worn reminder device (non-vibrating bracelet) and accompanying smartphone app that prompts for general context logging and delivers general health tips.
Interventions
Participants will receive an awareness bracelet (Keen2) which vibrates upon detection of hair pulling motion, supporting behavior therapy for hair pulling delivered by the Keen2 app.
Participants will receive a non-vibrating bracelet to wear as a visual reminder not to pull.
Participants will be given access to a smartphone app. The bracelet and app work together to implement key features of habit reversal training for TTM, including psychoeducation, awareness training, competing response training, and personalized just-in-time stimulus control and other behavioral strategy reminders.
Participants will be given access to a smartphone app that will prompt them to log their context (e.g., location and activity) throughout the day and provide general health tips.
Eligibility Criteria
You may qualify if:
- years of age or older (criterion 1a) with a diagnosis of TTM focused on primary hair pulling location(s) above the neck (e.g., scalp, eyebrows, eye lashes, beard) (criterion 1b).
- English language fluency (criterion 2).
- Report no current pharmacological intervention targeting TTM symptoms OR a 6-week course of the intervention without change in dosage and intent for that dosage to remain stable for the 12 weeks of this trial (criterion 3a).
- Report no current psychosocial intervention targeting TTM (criterion 3b)
- \. Reliable and consistent access to the internet and/or mobile device permitting the participant to meet with someone virtually for 90 min.
- \. Owns a mobile phone running on Apple's operating system (iOS 6+) 6. Identifies a support person that is able to be contacted if an emergency arises.
You may not qualify if:
- Current suicidal/homicidal ideation, intent, or plan (criterion 1a) or a diagnosis of another psychiatric condition that may impede a participant's ability to fully utilize the app (e.g., psychotic disorder, eating disorder, moderate to severe major depressive disorder \[defined by meeting diagnostic criteria on the MINI and a score \>13 on DASS-21\]) (criterion 1b)
- Has not used HabitAware's Keen or Keen2 bracelet in the past 24 months.
- Residing outside the United States
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HabitAware Inc.lead
- Kent State Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2021
First Posted
November 12, 2021
Study Start
March 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
February 23, 2026
Record last verified: 2026-02